Zydus Lifesciences Limited (NSE:ZYDUSLIFE)

Zydus Lifesciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 5, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	1,020,170	891,926	1,013,630	497,549	356,774	451,368
Market Cap Growth	-7.82%	-12.01%	103.72%	39.46%	-20.96%	64.98%
Enterprise Value	1,020,031	892,181	1,022,435	525,557	387,118	504,363
Last Close Price	1013.85	876.36	993.46	480.30	338.10	425.24
PE Ratio	22.31	19.71	26.26	25.38	7.95	21.16
Forward PE	22.93	19.01	28.46	21.39	16.57	26.84
PS Ratio	4.32	3.84	5.19	2.89	2.36	3.13
PB Ratio	3.87	3.38	4.59	2.53	1.87	3.02
P/TBV Ratio	6.59	5.76	8.48	4.28	3.40	7.04
P/FCF Ratio	-	17.61	44.27	30.01	39.56	18.50
P/OCF Ratio	-	13.16	31.71	18.50	16.95	13.70
PEG Ratio	1.55	2.15	1.53	1.79	3.03	1.51
EV/Sales Ratio	4.32	3.84	5.23	3.05	2.56	3.50
EV/EBITDA Ratio	14.87	13.06	19.45	14.87	12.21	14.77
EV/EBIT Ratio	17.19	14.97	22.53	18.42	15.65	18.44
EV/FCF Ratio	-	17.62	44.65	31.70	42.92	20.67
Debt / Equity Ratio	0.12	0.12	0.04	0.06	0.22	0.31
Debt / EBITDA Ratio	0.47	0.47	0.16	0.34	1.33	1.35
Debt / FCF Ratio	-	0.64	0.36	0.72	4.68	1.89
Asset Turnover	-	0.70	0.71	0.64	0.59	0.61
Inventory Turnover	-	1.77	1.87	1.81	1.64	1.64
Quick Ratio	-	1.12	1.30	1.05	0.96	0.57
Current Ratio	-	1.89	2.14	1.81	1.54	1.11
Return on Equity (ROE)	-	19.28%	18.90%	10.82%	13.96%	16.91%
Return on Assets (ROA)	-	11.21%	10.31%	6.66%	5.98%	7.19%
Return on Capital (ROIC)	13.95%	14.19%	12.95%	8.08%	7.22%	8.71%
Return on Capital Employed (ROCE)	-	21.20%	19.00%	14.10%	12.40%	17.10%
Earnings Yield	4.48%	5.07%	3.81%	3.94%	12.58%	4.73%
FCF Yield	-	5.68%	2.26%	3.33%	2.53%	5.41%
Dividend Yield	1.08%	1.26%	0.30%	1.25%	0.74%	0.82%
Payout Ratio	-	6.68%	16.09%	13.63%	8.29%	0.07%
Buyback Yield / Dilution	0.43%	0.56%	0.37%	0.79%	-	-
Total Shareholder Return	1.52%	1.82%	0.67%	2.04%	0.74%	0.82%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.